Thus having established SLIT2 as a lung and breast cancer suppressor gene, we have now identified frequent SLIT2 hypermethylation in paediatric cancers and in RCC and, recently, in 59% of gliomas (Dallol et al, 2003). Here, SLIT2 is linked to breast carcinoma.